-
SABCS 2024 | Dr. Jiong Wu: Exploring a New Era in Breast Cancer Treatment – In-depth Analysis and Future Perspectives from SABCS
At the recent San Antonio Breast Cancer Symposium (SABCS), Dr. Jiong Wu from Fudan University Shanghai Cancer Center and his team presented several significant research findings, offering new insights into breast cancer treatment.
-
SABCS2024 | Dr. Xiaojia Wang: New PD-1/VEGF Bispecific Antibody and ADC Introduce Novel Strategies, Multiple RWS Provide Key Insights for Comprehensive Breast Cancer Management
The 47th San Antonio Breast Cancer Symposium (SABCS) was grandly held from December 10–13, 2024, in San Antonio, USA, showcasing significant global advancements in breast cancer research. During the conference, Dr. Xiaojia Wang from the Cancer Hospital of the University of the Chinese Academy of Sciences (Zhejiang Cancer Hospital) presented several important research findings. These…
-
SABCS 2024 | Dr. Yiding Chen Interprets the INSEMA Study: New Evidence for Axillary Surgery De-escalation
The de-escalation strategy for axillary management in breast cancer has been a consistent research focus in breast surgery. Last year, the SOUND study explored whether certain low-risk patients undergoing breast-conserving surgery could avoid sentinel lymph node biopsy (SLNB). At the 2024 San Antonio Breast Cancer Symposium (SABCS), the INSEMA study, a similar investigation, was presented.…
-
Dr. Qiang Liu: Addressing Young Breast Cancer Patients and Exploring Innovations in Diagnosis, Treatment, and Recovery | 2024 Yixian Breast Cancer Conference
The “2024 Yixian Breast Cancer Conference and the Second China Young Breast Cancer Consensus Conference” took place in Guangzhou from December 27 to 28, 2024. The conference explored cutting-edge topics such as the evolving epidemiology of young breast cancer, screening strategies, the impact of genetic mutations, treatment, and recovery approaches. Highlights included the release of…
-
2024 CSCO YOUNG | Dr. Biyun Wang: Focusing on Cancer Treatment and the Development of Young Oncologists
On December 28, 2024, the year-end meeting of the Youth Expert Committee of the Chinese Society of Clinical Oncology (CSCO) was successfully held in Shanghai. This event brought together renowned experts and promising young talents from across the country to explore new directions in cancer treatment. Oncology Frontier had the honor of interviewing Dr. Biyun…
-
ASH 2024 | Dr. Kai Hu: Advancing CAR-T Therapy in Relapsed/Refractory Malignant Lymphoma and Multiple Myeloma
The 66th American Society of Hematology (ASH) Annual Meeting was held from December 7–10, 2024, in San Diego, USA. As one of the world’s largest international academic conferences in the field of hematology, ASH brings together cutting-edge research and the latest drug development data, showcasing the highest level of global hematology research. During this event,…
-
2024 Beijing City Annual Lung Cancer Conference | Dr. Yong Song: Advances and Challenges in Anti-Angiogenic Therapy for Lung Cancer
As the year draws to a close, reflection and progress take center stage. The “2024 Beijing Forbidden City Annual Lung Cancer Conference and the 16th Multidisciplinary Seminar on Advances in Lung Cancer Diagnosis and Treatment,” jointly organized by the Beijing Tumor Prevention and Research Association, the China Association of Senior Healthcare, the Beijing Medical Love…
-
ASH 2024 | Dr. Zhihui Li: Prognostic Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Advanced Relapsed/Refractory NKTCL Patients
The 66th American Society of Hematology (ASH) Annual Meeting was held from December 7–10, 2024, in San Diego, USA. As one of the largest global academic events in hematology, it showcased cutting-edge research and the latest drug development data. At this prestigious conference, Dr. Zhihui Li from Beijing GoBroad Boren Hospital (Dr. Tong Wu ’s…
Connecting Medical Expertise through Media